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Abstract
Effective treatment of depression involves collaboration with informed patients and
families and appropriate knowledge sharing. We describe here our experience, as a
case example, of a collaboration to “translate” a clinical guideline designed for practi-
tioners into an accessible, plainlanguage version that patients and families can use
during the care process, both to provide basic educational information and to foster
informed discussions with their treatment providers. Content experts in knowledge
translation, patient advocacy, patient‐oriented research, and psychiatry guided overall
project design. Our first step was to identify lived experience writers to join in the
codesign and co‐writing of the “CHOICE‐D Patient and Family Guide to Depression
Treatment.” A national call for writers attracted 62 applicants, from whom eight indi-
viduals with lived experience of depression and writing experience were selected.
Individuals subsequently attended a welcoming teleconference, followed by a 1‐day
workshop designed to provide (a) a detailed overview of the clinician guideline, (b)
an opportunity to select what should be included in the Guide, and (c) key principles
of knowledge translation/lay writing. Both from the workshop and subsequently
through the codesign process, lived experience writers recommended that the Guide
address symptoms, effects of illness course on treatment, first‐line treatments,
safety/side effects, and treatment misconceptions. To promote patient autonomy,
question scripts (how and what to ask your treatment provider), self‐triaging
resources, and treatment selection aids were suggested. Stylistic considerations
included use of simple yet hopeful language, brevity, white space, key terms glossary,
and graphics. Several strategies were particularly useful to optimize writer engage-
ment in the codesign process: a pre‐workshop conference call and circulation of pro-
ject resources, an in‐person workshop to increase content knowledge, structured
discussion with co‐writers and project leads to develop ideas, and practical training
exercises with the provision of feedback. Both during and at the end of the project,
writers provided additional recommendations for improving the process, including
more in‐person meetings, distribution of step‐by‐step instructions on the writing task,
and a key terms glossary of technical terms to support their role. In conclusion, we
describe a process with practical tips and reflective feedback on important
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considerations for engaging persons with lived experience as leaders in the codesign
and writing process of lay treatment guidelines. These methods may serve as a model
for similar projects in other areas of healthcare.
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1 | INTRODUCTION
Effective treatment of major depressive disorder (MDD) ideally
involves the collaboration of patients and practitioners in patient‐
centred care, using best practice as identified by evidence‐based treat-
ment guidelines. In 2016, the Canadian Network for Mood and
Anxiety Treatments (CANMAT) developed a third iteration of updated
guidelines for the clinical management of MDD, with new content on
burden and principles of care,1 psychotherapy,2 pharmacotherapy,3
neurostimulation,4 complementary and alternative medicine,5 and
special patient populations.6 Designed for clinicians, these guidelines
were generated using evidence review, expert opinion, and clinician
(end‐user) feedback. The 2016 CANMAT MDD guidelines evaluated
evidence published since the 2009 edition, with a focus on meta‐
analyses, systematic reviews, and randomized control trials. With the
use of level of evidence criteria, recommendations reflected both the
quality of the data and expert consensus. The expert consensus pro-
cess involved content experts in psychiatry, pharmacy, and psychology
who graded evidence and balanced side effect and other consider-
ations to generate treatment recommendation levels (eg, first‐line
treatment). Finally, external clinicians reviewed draft recommendations
to provide end‐user feedback, but patients were not incorporated into
this process.
Similar to the CANMAT MDD guidelines, most other clinical guide-
lines have been produced under the medical model,7 where clinicians
are considered to possess knowledge and expertise over what is best
for the patient. Consequently, the information presented within treat-
ment guidelines is often made inaccessible to patients, such as through
use of medical jargon that creates barriers in respect to language and
education. This has a negative effect on mental health literacy, which
refers to a patient's capacity to access, understand, evaluate, and com-
municate basic health information to effectively inform healthcare
decisionmaking.8 In fact, limited health literacy is a common phenom-
enon affecting 60% of Canadian adults, with outcomes varying accord-
ing to factors such as age, sex, level of education, geographic location,
and immigration status.9,10 Within mental health, there is an inade-
quate understanding of common symptoms, prevalence rates, risk fac-
tors, treatment options and their effectiveness, and crisis response
protocols, which can have secondary effects on negative and stigma-
tizing perceptions of mental illness, including treatment and recov-
ery.11,12 Other potential consequences include negative health
outcomes, reduced use of screening and preventative health services
and health‐promoting behaviours, increased hospitalizations, poor
treatment compliance, patient safety and mortality concerns, and
higher healthcare costs.9 In contrast, improvements in mental health
literacy have been shown to increase a patient's likelihood of sharing
decisions with their physician, verifying information credibility, and
exploring options beyond those presented by their healthcare team.13
Patient involvement in healthcare decision making is an important
aspect of optimizing the quality of mental health care being delivered
and is a predictor of improved clinical outcomes14 and increased
patient satisfaction.15 Moreover, how healthcare professionals support
patient autonomy in health‐care decision making has been shown to
influence overall patient engagement, specifically their participation
and health information–seeking behaviours, which can subsequently
affect treatment adherence.16
Consequently, there is an urgent need for patient education to
improve. In support, the recovery model for mental health7 has chal-
lenged more paternalistic approaches to treatment by placing patient
agency within healthcare decisionmaking at the centre of recovery
and healing. Under this model, patients are viewed as the experts of
their own circumstances and should be empowered to harness their
strengths and abilities to support their own recovery. This premise
can extend beyond increasing patient involvement in healthcare
decisionmaking to also include a direct role in the development and
delivery of mental health information and services. This stems from
the concept that persons with lived experience of mental illness have
unique perspectives and ideas on the impact of mental illness and
the navigation of mental health services that are informed by their
own recovery journey. The integration of these ideas with evidence‐
based data can be used to identify topics that are clinically impactful
for patients and can improve health satisfaction and optimize health
outcomes in the long‐term.17 The Mental Health Commission of
Canada (MHCC) has recognized these benefits and thus developed a
mental health strategy that identifies the lived experience voice as
an asset to recovery.18 Within this strategy, the MHCC recommends
that patients with mental illness, in addition to their families, assume
leadership roles in the planning, delivery, and evaluation of mental
health services to contribute to the meaningful transformation of the
mental healthcare system. Under this framework, clinical guidelines
can best support patient recovery when they are made available in
an accessible format using simplified language, coupled with the
involvement of persons with lived experience in the development
and dissemination process.
Many organizations have started to recognize the importance of
including person with lived experience within guideline development,
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such as the Guidelines International Network,19 the AGREE (Appraisal
of Guidelines, Research and Evaluation) Collaboration,20 and the
National Institute for Health and Care Excellence (NICE).21 NICE, for
example, has incorporated patient input into developing clinical guide-
lines for various acute and chronic clinical conditions such as cancer,
mental health, and women and child health.22 The World Health
Organization (WHO) is also incorporating patient feedback into
revising the diagnostic guidelines for the Mental, Behavioural and
Neurodevelopmental Disorders section of the International Classifica-
tion of Diseases (ICD)‐11 after finding that current content inade-
quately reflects the lived experience perspective and uses language
that is poorly understood and even objectionable to patients.23
Despite the growing inclusion of patient feedback into guideline
development, there is a paucity of lay language depression treatment
guides that present comprehensive, evidence‐based information for
patients using persons with lived experience as leaders in the writing
and dissemination process. This gap was identified in 2017 by the
Canadian Biomarker Integration Network in Depression (CAN‐BIND)
and the Mood Disorders Association of Ontario (MDAO), a patient
and family advocacy group. In response, a knowledge translation pro-
ject was initiated to adapt the CANMAT clinician guidelines into an
accessible, plain language version that incorporates the expertise of
individuals with lived experience. Termed the CHOICE‐D (CANMAT
Health Options for Integrated Care and Empowerment in Depression)
Guide, this patient and family guide to depression treatment was writ-
ten by patients (and families) with lived experience of MDD to
enhance patient‐centred care. The current report describes the proto-
col employed during Phase I of the CHOICE‐D project: the codesign of
the CHOICE‐D Guide with a Writing Committee composed of persons
with lived experience of mental illness (see Figure 1). The codesign
process refers to content selection for the Guide, in addition to graphic
design, formatting, and layout considerations.
2 | APPROACH TO PROJECT DESIGN AND
PARTICIPANT TRAINING
2.1 | Expert consultations
Informal consultations with 10 content experts in knowledge transla-
tion, patient advocacy, patient‐oriented research, and psychiatry were
completed (see Table 1). The purpose of the consultations was
twofold: (a) to define the composition and scope of the Writing
Committee and (b) to design an in‐person workshop to provide train-
ing to members of the Writing Committee on their project roles and
responsibilities and engage them in the codesign process for the
CHOICE‐D Guide (see Figure 2). Consultations were completed either
in person or via teleconference. Experts provided insights and ideas for
project development and recommended knowledge translation litera-
ture for review to identify optimal methods for patient education
and engagement.
2.2 | Writing Committee
The MDAO released a national call inviting individuals with lived expe-
rience, either direct or indirect, of mood disorders and mental health
service navigation from across Canada to join the Writing Committee.
Stringent selection criteria were not imposed during the process to
increase the breadth of applicants who were eligible to apply. For
those with direct lived experience, there were no specific eligibility
FIGURE 1 CHOICE‐D project stages
TABLE 1 Content experts consulted for the CHOICE‐D Guide
Expert Type
Number
Interviewed Area of Expertise
CHOICE‐D, Project
Leadsa


















Patient advocates 1 Healthcare advocacy; patient‐
oriented research
Abbreviations: CANMAT, Canadian Network for Mood and Anxiety Treat-
ments; CHOICE‐D, CANMAT Health Options for Integrated Care and
Empowerment in Depression.
aIncludes representatives from the partnering organizations of CANMAT,
the Canadian Biomarker Integration Network in Depression, Mood Disor-
ders Association of Ontario, and Ontario Brain Institute.
bTwo section leads are also represented under “CHOICE‐D Project Leads.”
FIGURE 2 The use of expert consultations to inform CHOICE‐D
project methods
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criteria involving the type of mood disorder, symptom length and
severity, or treatments used, but applicants needed to confirm a level
of current symptom stabilization that would allow them to manage
the workload of the project. Project leads received 62 applications
and invited 13 to interview; of these, eight applicants were selected,
but one writer withdrew their participation for personal reasons prior
to project onset (see Figure 3). Based on the applicant pool, and as
advised by our expert consultants, applicants were primarily selected
based on skills and experiences in areas such as writing, editing, com-
munications, graphic design, marketing, healthcare/health research,
and work with the vulnerable sector to more directly support project
objectives. The focus on member expertise was to permit engagement
at all stages of Guide development, where possible, to ensure rele-
vance to end‐users and enhance quality. Demographic diversity was
a secondary consideration to increase the range of experiences and
insights offered. To see the demographic composition of the
CHOICE‐D Writing Committee, refer to Table 2. All Writing Commit-
tee members confirmed their comfort in articulating ideas verbally in
a group setting and in written format. Writing Committee members
were financially compensated for their involvement in the project.
Project leads were transparent about project goals, anticipated
workload, and the projected timeline for deliverables at outset.
2.3 | Writer workshop
A full‐day workshop was delivered to provide training to members of
the Writing Committee before onset of the translation and writing
phases. There were four main goals for the workshop: (a) to provide
an opportunity for the team to meet each other in person; (b) to
provide writers with a common foundation of knowledge on the
CANMAT guidelines, the writing process, and other writing consider-
ations; (c) to discuss content priorities for inclusion (or exclusion)
in the CHOICE‐D Guide on the basis of the lived experience perspec-
tive; and (d) to determine writing subgroups. To ensure all Writing
Committee members understood the content of the original guide-
lines, a copy of the CANMAT Guidelines and lay summary notes on
each section were distributed prior to the workshop to allow sufficient
time for review. Writing Committee members were encouraged to
familiarize themselves with the content while noting any areas of
uncertainty and questions on the material for clarification and group
discussion. A conference call was also held in advance of the workshop
to provide opportunity for Writing Committee members (and project
leads) to introduce themselves, receive an overview of the workshop
including key objectives and goals, ask questions, and facilitate
discussion.
The workshop, designed by integrating evidence‐based research
and recommendations from expert feedback, was divided into two
parts. The first part offered training sessions to support the Writing
Committee in their project role. The Writing Committee was also pro-
vided with the resources and information they would need to develop
the Guide. The second part focused on content selection for the Guide
since only certain sections were translated from the original CANMAT
guidelines to ensure brevity and accessibility (see Figure 2). Members
of the Writing Committee were also given opportunity to get to know
one another and share their experiences to facilitate bonding and mit-
igate any social anxieties. All writers were provided with hard copies of
the workshop material, in addition to paper and pens for them to doc-
ument any ideas or suggestions in the absence of an immediate oppor-
tunity to share them. Evaluations were provided at the end of the
workshop to collect writer feedback on the codesign process.
2.4 | Writer training
The workshop provided didactic instruction interspersed with individ-
ual and interactive activities that allowed members of the Writing
Committee to practice newly learned skills, provide their perspectives
and opinions, and facilitate feelings of engagement and cohesion.FIGURE 3 CHOICE‐D recruitment process






20‐29 y 3 (42.9%)
30‐39 y 1 (14.3%)
40‐49 y 2 (28.6%)






Note. Based on seven completed responses.
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Three training sessions (and related activities) on writing stylistics,
clear language and design, and editing were provided. Individual train-
ing sessions were limited to 20 minutes to minimize burnout and
fatigue. Writing Committee members also completed a lay translation
exercise that resembled the translation task they would be assigned
for the CHOICE‐D Guide, which necessitated application of all the
skills learned during the workshop. This exercise required the Writing
Committee to translate an excerpt from the original CANMAT
Guidelines into plain‐language text using the “Think (individual)‐Pair
(small group, in pairs)‐Share (larger group discussion)” method.24
Feedback from the activity was immediately provided during a group
discussion, where translation challenges and potential strategies were
also reviewed.
2.5 | Content selection
The latter half of the workshop was spent distilling tangible points of
information for translation such as content, structure, and order of
presentation. Content selection was facilitated through discussions
about “must‐haves” for the CHOICE‐D Guide and use of a content pri-
oritization scoring activity. Scoring was completed for sections on
“Disease Burden and Principles of Care,” “Psychotherapy,” “Pharmaco-
therapy,” and “Complementary and Alternative Medicines”; the
“Neurostimulation” section was discussed but not scored because of
a primary focus on first‐line treatments. During this activity, the
Writing Committee provided feedback on which subsections of the
original CANMAT guidelines should be included (or excluded) in the
translated version on the basis of a lived experience perspective of
topic relevancy for mental health service navigation and engagement
in mental health‐care decisionmaking. To facilitate prioritization, mem-
bers provided a score of “yes“, “maybe“, or “no“ for each subsection.
The group erred on the side of over‐inclusion where, if the number
of combined votes for yes and maybe exceeded the number of votes
for no, then the subsection would be included in some capacity. The
activity was accompanied by active group discussion to share personal
insights for score assignment and to ensure that all members of the
Writing Committee were agreeable with final decisions. Use of this
format allowed member feedback to be weighed equally, with the
majority consensus dictating final outcomes. To ensure that potential
Writing Committee biases or conflicts did not influence content trans-
lation, a moderator was appointed to put ideas in context and balance
different points of view. Feedback was also collected on the order of
presentation, graphic design considerations, and the development of
clinical tools that can be used by patients to facilitate discussions with
their mental health practitioner(s) and support healthcare
decisionmaking. Regardless of the sections selected for translation in
the CHOICE‐D Guide, all original content is still available to lay audi-
ences through the CANMAT guidelines. The translated Guide does
not aim to remove any content per se but only to highlight aspects
that are deemed to be particularly interesting and relevant to patients
(and their families) for mental health treatment, as based on the lived
experience perspective of the Writing Committee.
3 | IMPLEMENTATION STEPS IN PROJECT
AND REFLECTIVE FEEDBACK
3.1 | Guide scope
The Writing Committee identified the main purpose of the translated
Guide as “to facilitate conversations with healthcare providers and to
help build a sense of agency.” The Writing Committee believed that
the Guide should be written with the following end‐users in mind: indi-
viduals with depression, caregivers (eg, parents, children, siblings, and
friends), healthcare providers, and staff at various resource centres.
The Writing Committee further believed that these end‐users may
be facing potential challenges that include: fear of stigma including
cultural‐ and faith‐related stigma, English literacy barriers, limited
access to comprehensive care, family changes (eg, divorce, death,
and pregnancy), environmental changes (eg, starting school or a new
job), and financial difficulties. To reach these end‐users, the Writing
Committee believed the Guide should be distributed at drop‐in clinics,
emergency rooms, learning institutions (eg, high schools, universities,
and colleges), community centres, homeless shelters, faith centres,
and senior centres. These concepts influenced how the Writing
Committee chose to shape the Guide.
3.2 | Translation exercise
After completing the lay translation exercise, the Writing Committee
identified challenges with extracting essential information, under-
standing the material, and feeling overwhelmed or anxious with the
translation task. Group discussion generated the following strategies
to address these challenges: using “who, what, where, when, why,
and how“ questions to condense the message, cutting out extraneous
or irrelevant information, considering the audience, identifying which
sections could be supplementary, isolating the take home message,
and consulting with others.
3.3 | Content selection and development
The Writing Committee elected to retain the majority of subsections
from the original CANMAT guidelines, with the exception of 11, which
they believed would be unhelpful for end‐users (see Table 3). Of these
sections, writers prioritized content on psychotherapeutic options
over pharmacotherapy. There were also several content areas that
the Writing Committee felt were pertinent to address (see Table 4).
In addition to section prioritization, other considerations were
noted: Disease Burden and Principles of Care: There were recommenda-
tions to include symptom summaries that support end‐users in recog-
nizing the signs of both depression and suicidality. When transitioning
into treatment overviews, the effects of illness stage (eg, initial diagno-
sis, a few treatments tried, and multiple treatment “failures”) and
severity on treatment outcomes should be included. Psychotherapy:
The Writing Committee recommended providing tools on selecting
the best type of therapy, including tips on what to look for in a
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therapist and how to select between group, individual, and online for-
mats. Pharmacotherapy: Reference to terms such as “treatment‐
resistant depression” was deemed to have a discouraging connotation,
and thus alternate language should be used. Including a section on
new treatments under development may offer hope to those strug-
gling to find effective medications. Neurostimulation: Coverage should
review electroconvulsive therapy and repetitive transcranial magnetic
stimulation over other treatments. Across sections, first‐line treat-
ments and their effectiveness should be conveyed, in addition to a
review of common and readily available options. Treatments should
also be reviewed in respect to safety and side effect considerations,
and treatment misconceptions or myths should be dispelled. Writers
also opted to include crisis line information at outset, and quick refer-
ence summary sections for the entire Guide.
One overarching principle endorsed by the Writing Committee was
to support patient autonomy, particularly by developing supplemental
resources. The Writing Committee recommended developing a tool
that can enhance end‐user involvement in healthcare decision‐making,
particularly by informing how to ask a healthcare provider “the right
questions.” A self‐triaging tool that helps end‐users evaluate illness
severity to determine when to visit a doctor or hospital or access other
resources was recommended. Finally, inclusion of a decision‐tree flow
chart that assists end‐users with selecting suitable treatment was also
suggested.
A guiding principle was to “keep it simple” but to “keep it informa-
tive.” The amount of included information should be limited to pre-
vent end‐users from feeling overwhelmed. However, since some
readers may want more information; content could be organized into
a “top‐line” section, which will be most visible; and a “more informa-
tion” section which end‐users can access for additional details. The
Writing Committee agreed that providing access to the full CANMAT
guidelines is important for this subsection. The text should ideally be
presented in point form, and graphics should be included whenever
possible. The Writing Committee further recommended inclusion of
a glossary of key terms and treatments to simplify usability. The Guide
could also include an “additional wisdom” section, written from the
lived experience perspective of the Writing Committee, to provide
real‐world advice on managing depression treatment that is clearly
distinguishable from research. Finally, since there are
specific considerations for special patient populations, separate
documents or different adaptations may be needed to capture this
information.
3.4 | Workshop feedback
Overall, the Writing Committee evaluated the workshop positively
(see Figure 4A). In assessing learning outcomes, 86% of attendees felt
that they gained knowledge of the CANMAT guidelines, and 71% felt
more informed about the writing process. All Writing Committee
members thought the workshop was easy to understand, and 67%
believed that the information they received would support their role
as a writer. Consequently, the Writing Committee expressed high
levels of confidence to serve as a writer for the CHOICE‐D Guide
TABLE 3 CANMAT sections to exclude on the basis of a content
prioritization exercise
Disease burden and principles of care
Section 1.5. What is the disease burden associated with MDD?
Section 1.6. What is the occupational impact of MDD?
Section 1.8. What is the impact of MDD on physical health?
Section 1.9. How does MDD typically present in clinical practice?
Section 1.10. What are the basic principles of clinical management?
Section 1.12. What is measurement‐based care?
Section 1.14. What are the goals of acute and maintenance
treatment?
Psychotherapy
Section 2.4. How do gender and age influence the decision to use
psychological treatment?
Section 2.14. What is the overall level of efficacy for motivational
interviewing in the acute and maintenance phases of MDD treatment?
Pharmacotherapy
Section 3.2. What antidepressants are newly approved?
Section 3.11. Are there differences in formulations of specific
antidepressants?
Complementary and alternative medicines
None
Abbreviations: CANMAT, Canadian Network for Mood and Anxiety Treat-
ments; MDD, major depressive disorder.
TABLE 4 Summary of Guide development feedback
Recommendations for content
• Provide symptom summaries for MDD and suicide
• Address effects of illness stage and severity on treatment outcomes
• Communicate first‐line treatments and their effectiveness
• Address safety and side effects
• Address treatment misconceptions or myths
Recommendations to promote patient autonomy
• Include question scripts on what to ask your doctor
• Include self‐triaging resources
• Include decision‐tree flow chart for treatment selection
Recommendations on clear language and design
• Keep it simple but also informative
• Avoid negative or discouraging language; focus on messages of hope
• Be mindful of document length and include access to supplemental
information
• Use point form and graphics
• Include glossary of key terms and treatments
• Include real‐world advice from persons with lived experience
• Offer guide adaptations for special patient populations
Abbreviation: MDD, major depressive disorder.
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(see Figure 4G). Half of the Writing Committee also expressed interest
in being involved in other stages of Guide development beyond
writing, including editing, graphic design, and dissemination.
In providing a more detailed assessment of workshop structure, the
Writing Committee was particularly pleased with the inclusion of a
pre‐workshop conference call, coupled with the opportunity to receive
FIGURE 4 Writing Committee feedback on
workshop
FONSEKA ET AL. 7FONSEKA ET AL. 1265
introduction to other writers. In respect to content, attendees found
the translation exercise, group content review of the CANMAT guide-
lines, and content prioritization activity to be most valuable. However,
29% of attendees still requested that project leads provide additional
resources to support their role as a writer. More specifically, Writing
Committee members requested step‐by‐step instructions on how to
translate clinical text, more concrete examples of lay translations, a
translation toolkit including more resources for plain language writing,
and a glossary defining technical terms found in the original CANMAT
guidelines. There was also a recommendation to include more wellness
breaks throughout the workshop.
4 | DISCUSSION
Improving health care involves integration of multiple perspectives and
different types of evidence. Two leading components of efforts to
improve health care involve enhancing patient involvement and
increasing use of evidence‐based care. For enhanced patient involve-
ment, key attributes include involving patient stakeholders in all
aspects of health care design and implementation, and use of shared
decision‐making (by patient and provider) at the point of clinical con-
tact. For increasing evidence‐based medicine, attention to clinical
guidelines may provide an optimal summary of relevant treatments.
In this article, we have described a unique process where we used
principles of knowledge translation, patient engagement, and
evidence‐based medicine to develop a codesign team that was pre-
dominantly composed of individuals with lived experience of mood
disorders. Our team subsequently evaluated, rewrote, and extended
a traditional CANMAT clinical treatment guideline for MDD into the
plain ‐anguage “CHOICE‐D Patient and Family Guide to Depression
Treatment.” Our report provides details of our approach, based on
feedback from professionals and lay members of the team, on how
to optimize efforts to create other patient and family guides. To the
authors' knowledge, inclusion of lived experience writers has yet to
be done in the translation of clinical depression treatment guidelines
into a lay language patient guide. In fact, the involvement of patients
in any capacity within guideline development has been shown to be
quite infrequent, occurring less than 25% of the time, despite the doc-
umented benefits.25 As demonstrated within this report, the involve-
ment of patients within the codesign process has the potential to
optimize the final Guide, such as by identifying target populations
and end‐user considerations, prioritizing content selection, outlining
graphic design considerations, suggesting real‐world tools to increase
effectiveness, incorporating the lived experience perspective to more
directly support patient needs, and suggesting suitable dissemination
strategies to increase uptake.
The methods used in this project provide unique insights on how to
effectively engage a patient Writing Committee throughout the code-
sign process. For one, the Writing Committee noted the benefits of a
pre‐workshop call to informally meet the other writers and projects
leads, become acquainted with the material and process, and ask ques-
tions. This was coupled with the circulation of project materials and
resources with sufficient time for the Writing Committee to review
prior to the in‐person workshop. The inclusion of a phone meeting
provided writers with the opportunity to prepare for the workshop
and start generating ideas, opinions, and further questions. Increasing
content knowledge allowed the writers to improve their confidence
on the topic and feel more comfortable actively contributing to the
group discussion. The opportunity to receive introductions to fellow
co‐writers also visibly helped to mitigate social anxieties, which per-
mitted increased collaboration among writers during the workshop.
These findings are supported by data suggesting that insufficient con-
tent knowledge and poor group dynamics are barriers to successful
patient participation in guideline development.26 Moreover, the call
further improved the writers' level of comfort with project leads and
helped to reduce any perceived power differentials, which can nega-
tively affect participation because of increased intimidation.26
Similarly, the provision of an in‐person workshop, which has been
shown to enhance patient engagement in guideline development,27,28
further supported the Writing Committee in obtaining knowledge on
how to complete their role as a writer for the Guide. The Writing
Committee shared that receipt of information within training sessions
and practical exercises allowed them to feel better prepared to partic-
ipate in the project and increased their interest in expanding their
involvement to other project tasks beyond writing. The lay translation
activity was particularly useful in improving writer confidence by pro-
viding them with an opportunity for direct practical exposure to and
feedback on their upcoming translation task. Writers further expressed
that the Think‐Pair‐Share format was preferable because it gave them
an opportunity to develop their own ideas and work through areas of
uncertainty with someone in a safe space with ample opportunity for
equal discussion. In particular, being able to share ideas with another
person helped writers determine if they were approaching lay lan-
guage translation correctly without being intimidated or embarrassed
within a larger group. However, the large group discussion towards
the end was deemed to be a beneficial learning opportunity to hear
about other challenges to potentially expect and more translation
strategies to consider. The benefits of the full group discussion were
also acknowledged during the content prioritization and development
activities, which helped writers process and refine ideas and sugges-
tions for the Guide. This aligns with other data that have shown that
group discussion can assist participants with generating ideas by build-
ing on shared experiences and perspectives and by posing questions to
one another.29 Moreover, having a moderator allowed all writer pref-
erences to be weighed equally to ensure no one was excluded from
the process and that the final product would best represent the lived
experience perspective.
Nevertheless, the workshop on its own was insufficient to meet
the needs of the writers, who requested more step‐by‐step instruc-
tions and translation tool kits that could be referenced while complet-
ing the writing task. This suggests that although writers need training
opportunities and resources to improve their content knowledge, it is
essential to present this information in a simplified manner that can
be translated into discrete steps for how to approach the assigned
task. Presenting too much information and complex concepts or using
8 FONSEKA ET AL.1266 FONSEKA ET AL.
unfamiliar technical terms make it difficult for writers to extract what
is needed to complete their project responsibilities.28,30 Instead, pro-
ject leads should provide writers with easy‐to‐use instructions on the
translation process (and other writer tasks) that would be a useful
aid during the writing process.
During the codesign process, the writers recommended that the
Guide contain content that addresses symptoms, effects of illness
stage and severity on treatment outcomes, first‐line treatments and
their effectiveness, safety/side effects, and treatment misconceptions.
This selection was based on the lived experience perspective regarding
which information would be most interesting to patients (and their
families) and relevant to increasing patient understanding of their
mental health treatment, as informed by the writers' own experiences
navigating the mental health‐care system. Similarly, the Writing
Committee requested the addition of question scripts, self‐triaging
resources, and treatment selection aids to improve patient autonomy
and to increase the uptake of the Guide in real‐world patient settings.
In fact, the inclusion of tools that encourage asking question, particu-
larly questions that address the main medical concern, next steps, rel-
evant treatment options, and all the whys, have been shown to
improve patient engagement.31,32 In respect to stylistic considerations,
writers opted for the use of simple yet hopeful language, brevity, and
short content sections surrounded by ample white space and graphics
to make the Guide less overwhelming, and the addition of a key terms
glossary for quick reference. Overall, the recommendations generated
by the Writing Committee are highly aligned with the information
extracted from the knowledge translation literature on how to best
improve health literacy rates.31,33 The literature suggests that use of
patient‐based interventions that adhere to these formats has the
potential to improve patient engagement and satisfaction.34
Despite the strengths of the applied codesign methodology, the
recruitment process for the Writing Committee had some limitations.
Since a major consideration was to ensure writer engagement
throughout all stages of project development to maximize the lived
experience perspective, project leads emphasized skills and experi-
ences as the primary basis for Writing Committee selection. This deci-
sion was not only based on feedback received from our expert
consultants, but it also aligns with criteria used in other patient guide-
line development groups.26 In doing this, demographic characteristics
were secondary considerations. Use of this approach limited the diver-
sity of our Writing Committee, particularly in regard to gender, ethnic-
ity, and geographic location of residence (see Table 2). Moreover,
project leads were also restricted to the pool of applicants that applied
to be part of the Writing Committee, as multiple applicant calls or
recruitment of specific individuals known to project leads to fulfil
demographic quotas was not performed. However, future patient
groups should be diverse in as many aspects as possible to ensure
the final Guide resonates with various readers.30 Geographic diversity
is important to gain insights into mental health resource limitations and
accessibility concerns, such as those affecting patients in rural areas.
Applicants with varied educational backgrounds, occupational/
employment statuses, and socio‐economic statuses should be consid-
ered, as they may inform how untreated mental illness can create
barriers for work or school and even for securing treatment. Age con-
siderations should be addressed by including at least one youth and
older patient representative to inform content and language. Patient
writing groups should also be balanced in respect to sex, which can
provide insights into both biological and social differences that can
affect treatment options, such as treatment changes in the event of
pregnancy and breastfeeding,6 for example. Representation from vari-
ous ethnic and cultural groups informs treatment perspectives beyond
Western medicine and is especially important considering the multicul-
tural landscape of the Canadian context in which the Guide will be
offered. To address these limitations for the CHOICE‐D Guide, diver-
sity profiles will be expanded during the editing process, as the Guide
will be distributed to anyone who is interested in reviewing it, and
their feedback will be integrated into the final version. Culturally
diverse groups will also be included in other aspects of Guide develop-
ment, such as dissemination, delivery of educational workshops on
Guide use, and content translation into additional languages or cultur-
ally‐informed versions. Use of this process will ensure that any missed
content, perspectives, or considerations that are integral to the overall
quality of the Guide be identified and added.
In terms of the next steps, members of the Writing Committee
were organized into writing subgroups and randomly assigned content
from the CANMAT guidelines to translate at the end of the in‐person
workshop; these subgroups have since moved into the writing phase
of the project. During the writing process, project leads will be avail-
able to support writers as needed to reduce burden. Moreover, atten-
tion to writer mental wellness is an important consideration, and
development of good rapport and an open dialogue with writers will
facilitate disclosure if more supports are needed. Although project
deadlines are an important consideration, it is imperative to place
writer wellness as a priority and to clearly articulate this to the Writing
Committee. Consequently, deadlines will need to be flexible, and this
should be communicated to all involved stakeholders at outset. The
Writing Committee will remain involved during the editing phase to
ensure that the final document is aligned with their original vision
and retains the lived experience perspective. Several iterations of
editing will be included in the development process and will involve
additional persons with lived experience of depression and other
stakeholder groups to broaden the scope of the feedback received.
Upon Guide completion, writers will be invited to support dissemina-
tion to the extent that they are advocating for people with depression,
with potential utility as community presenters or promoters via social
media. There may also be opportunity to create accessible videos on
how to use the Guide to increase uptake.
The creation of patient‐developed depression guidelines is a novel
initiative with ground‐breaking clinical implications for patients
(and families), which include improved understanding of treatment
options, greater involvement in health care decision making, and
increased satisfaction in primary and secondary health care. This
report adds to the literature by addressing important considerations
for actively engaging persons with lived experience of depression as
leaders in the codesign and writing process of lay treatment guidelines.
This methodology provides a model that can be used to inform the
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creation and engagement of other patient groups within guideline
development, particularly the codesign process, to ultimately produce
a product that has real‐world utility for patients and their families.
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